Cardiovascular diseases (CVD), such as heart attack and stroke, are responsible for almost one in three deaths worldwide. Hypertension, the main clinical risk factor for CVD, is responsible for over 9.4 million largely preventable deaths globally each year: it is clear that broad-scale hypertension treatment programs are urgently needed.
Supported by the US Center Centers for Disease Control and Prevention (CDC) and the Pan American Health Organization (PAHO), this Web Forum will outline the global case for improving hypertension awareness, treatment, and control. We will discuss details of successful approaches to achieving high levels of population hypertension control, including the success stories of Canada’s Hypertension Education Program and Kaiser Permanente’s PHASE Program in the United States. Inspired by these and other experiences, CDC, PAHO, and leading experts and organizations in hypertension and cardiovascular health came together to create the Global Standardized Hypertension Treatment Project (GSHTP). Leading experts will discuss the development and implementation of the GSHTP framework for standardizing the treatment of hypertension using medications, enhancing the availability of core medications, and identifying key elements of care delivery in the Latin America and Caribbean Region and beyond.
Specifically, this interactive forum and roundtable session will:
- Provide a global perspective on the impact of hypertension on individuals, communities, health systems, and countries.
- Share examples of successful approaches to treat and control hypertension from organizational, country, and multi-country levels.
- Outline available global hypertension resources to advance hypertension awareness, treatment, and control.
Centers for Disease Control and Protection
Tom Frieden, MD, MPH, became Director of the Centers for Disease Control and Prevention (CDC) in June 2009. Dr. Frieden has worked to control health threats from infectious diseases, respond to emergencies, and battle the leading causes of suffering and death in our nation and around the world.
General Internist, Professor of Medicine
University of Calgary
- President, World Hypertension League,
Dr. Campbell is a General Internist, a Professor of Medicine, Community Health Sciences and Physiology and Pharmacology and a member of the O’Brien Institute of Public Health and Libin Cardiovascular Institute of Alberta at the University of Calgary. He also serves as the HSF CIHR Chair in Hypertension…
Clinical Leader, Cardiovascular Risk Reduction (PHASE) Program
Kaiser Permanente, Northern California
South San Francisco, CA
- Clinical Leader, Care Management Institute (CMI) Kaiser National Integrated Cardiovascular Health Guideline Team , Kaiser Permanente, South San Francisco, CA
Dr. Jaffe is the Clinical Leader of the Kaiser Permanente Northern California Cardiovascular Risk Reduction (PHASE) Program, and has served in this position since the program was established in 2004. Dr. Jaffe also serves as the Clinical Leader of the Care Management Institute (CMI) Kaiser National Integrated Cardiovascular Health Guideline…
Senior Medical Officer and Special Projects Lead, Noncommunicable Diseases Unit, Division of Global Health Protection
Center for Global Health Centers for Disease Control and Prevention (CDC)
Dr. Pragna Patel is the Special Projects Lead for the Global Noncommunicable Diseases (NCD) Unit in the Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention (CDC). She joined the NCDU in August 2013 to provide leadership to NCD special projects, such as the…
Director, Getting it Right from the Start: Local Regulation of Recreational Marijuana
Public Health Institute
- Senior Advisor, Public Health Institute, Oakland, CA
- Clinical Professor, University of California San Francisco, San Francisco, CA
Dr. Lynn Silver, a pediatrician and public health advocate, is Senior Advisor at the Public Health Institute and Clinical Professor at University of California San Francisco. She focuses on policies to prevent noncommunicable disease, its risk factors and inequitable impact. Her interest in local marijuana regulation arose from her experience as…